Compare GLMD & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLMD | RETO |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 6.1M |
| IPO Year | 2014 | 2017 |
| Metric | GLMD | RETO |
|---|---|---|
| Price | $0.83 | $1.83 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 91.9K | ★ 253.3K |
| Earning Date | 11-26-2025 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,109,956.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16864.81 |
| 52 Week Low | $0.73 | $1.66 |
| 52 Week High | $3.50 | $61.50 |
| Indicator | GLMD | RETO |
|---|---|---|
| Relative Strength Index (RSI) | 42.15 | 42.38 |
| Support Level | $0.73 | $1.81 |
| Resistance Level | $0.88 | $1.98 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 41.20 | 27.59 |
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Machinery and Equipment sales, and Technology Consulting and other services. The company earns its revenue from the Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.